Benzenethiol

Benzenethiol

SCHEMBL3297154

CCN(CC)CC.Sc1ccccc1.Sc1ccccc1.Sc1ccccc1.[SnH2]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 2/20 0.43
▸ CHRM2 P08172 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ DRD1 P21728 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ OPRM1 P35372 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ SLC6A3 Q01959 1/20 0.43
▸ SIGMAR1 Q99720 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ AGTR1 P30556 1/20 0.37
▸ CNR2 P34972 1/20 0.36
▸ TSHR P16473 4/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzenethiol SCHEMBL8812966 0.97 KCNH2 (0.45) KCNH2CHRM2HTR1AADRA2ACHRM1
Benzenethiol SCHEMBL8716349 0.97 KCNH2 (0.45) KCNH2CHRM2HTR1AADRA2ACHRM1
Benzenethiol SCHEMBL8716345 0.97 KCNH2 (0.45) KCNH2CHRM2HTR1AADRA2ACHRM1
Benzenethiol SCHEMBL5961852 0.85 ALDH1A1 (0.38) KCNH2CHRM2HTR1AADRA2ACHRM1
Benzenethiol SCHEMBL4339471 0.82 CHRM1 (0.35) KCNH2CHRM2HTR1AADRA2ACHRM1
Benzenethiol SCHEMBL28133317 0.81 ALDH1A1 (0.41) KCNH2CHRM2HTR1AADRA2ACHRM1
Benzenethiol SCHEMBL27710185 0.81 TP53 (0.45) ALDH1A1TSHRTP53
SCHEMBL11315098 0.80 HRH3 (0.34) KCNH2CHRM2HTR1AADRA2ACHRM1
Benzenethiol SCHEMBL28328862 0.78 IDO1 (0.43) TSHRTP53
Benzenethiol SCHEMBL28174992 0.78 TP53 (0.43) KDM4EMAPTTSHRTP53LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737129-B2 Substituted liposaccharides useful in the treatment and prevention of endotoxemia EISAI R & D MANAGEMENT CO., LTD. (JP) 2010-06-15 — — US disclosed
US-20080214802-A1 Substituted Liposaccharides Useful in the Treatment and Prevention of Endotoxemia EISAI CO., LTD. (JP) 2008-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214802-A1 Substituted Liposaccharides Useful in the Treatment and Prevention of Endotoxemia LIPG, FUT6, UGCG KCNH2 4758/4885CHRM2 4197/4885HTR1A 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback